A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications
- 1 April 2021
- journal article
- editorial
- Published by Elsevier in Vascular Pharmacology
- Vol. 137, 106826
Abstract
No abstract availableFunding Information
- National Institute of General Medical Sciences
- National Heart, Lung, and Blood Institute
This publication has 20 references indexed in Scilit:
- Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In VivoImmunity, 2011
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogensJournal of Leukocyte Biology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Pathways for bradykinin formation and inflammatory diseaseJournal of Allergy and Clinical Immunology, 2002
- Altered Neutrophil Homeostasis in Kinin B1 Receptor-Deficient MiceBiological Chemistry, 2001
- Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions.1997
- Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactionsClinical & Experimental Allergy, 1997
- Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptidesJournal of Biological Chemistry, 1993
- Bradykinin and inflammatory painTrends in Neurosciences, 1993